Forty-one strains of Streptococcus mutans (34 from blood specimens from patients with endocarditis and 7 from stock cultures) were tested for susceptibility to penicillin, ampicillin, methicillin, erythromycin, cephalothin, vancomycin, chloramphenicol, tetracycline, gentamicin, streptomycin, and kanamycin. Minimal inhibitory and bactericidal concentrations were determined by a broth microdilution procedure. Most of the strains were very susceptible to ampicillin, penicillin, and erythromycin, with most strains having minimal inhibitory concentrations of 0.08 ug/ml or less. Most of the strains were also susceptible to cephalothin, methicillin, chloramphenicol, tetracycline, and vancomycin. Gentamicin was the most effective aminoglycoside. The antimicrobial susceptibility patterns are similar to those of other viridans streptococci. S. mutans strains have proven to be difficult for some microbiologists to identify. But when organisms suggesting S. mutans are isolated from patients with endocarditis, they should be at least identified as nonenterococcal streptococci so that appropriate therapy can be initiated.
The purpose of this study was to determine the susceptibility of 41 strains of S. mutans (34 from cases of endocarditis) to 11 antibiotics.
MATERIALS AND METHODS Cultures. The streptococcal strains were received in the Streptococcus Unit, Center for Disease Control (CDC), through state health departments, and from certain individual investigators by special arrangements (John A. Washington, Mayo Clinic, Rochester, Minn., and Phillip I. Lerner, V.A. Hospital, Cleveland, Ohio). Of the 41 strains used in this study, 7 were stock cultures and the remaining 34 were from cases of endocarditis. Only one isolate per case was included.
The cultures were identified by R. R. Facklam of the Staphylococcus and Streptococcus Unit, CDC, by methods previously described (M. Plaut et al., submitted for publication). These organisms are members of the viridans group of streptococci and can be speciated on the basis of three typical reactions: (i) acid in mannitol broth, (ii) crystalline-like adherant colonies on 5% sucrose agar, and (iii) sticky gelatinous deposits in a tube of 5% sucrose broth.
Antibiotics. The eleven antibiotics used in this study and their sources were ampicillin, methicillin, and kanamycin from Bristol Laboratories; erythromycin, cephalothin, and vancomycin from Eli Lilly & Co., penicillin from Wyeth Laboratories; gentamicin from Schering Corp.; streptomycin and tetracycline from Pfizer Laboratories; and chloramphenicol from Parke, Davis & Co.
Stock solutions of the antibiotics were made with appropriate diluents. Further dilutions were made in Trypticase soy broth (TSB) to a concentration twice that of the highest concentration to be tested. Serial twofold dilutions were made in microtiter plates either manually or automatically with an Autotiter (Canalco). The plates containing the diluted antibiotics were stacked on top of each other in groups of six plates. Each stack was covered with an empty plate and sealed in a plastic bag. These plates containing diluted antibiotics were then stored at -65 C. The plates were removed as needed and were allowed to come to room temperature before inoculation.
Susceptibility tests. Cultures were streaked onto (9) reports that some of the organisms that were isolated from blood in previous years and identified as Streptococcus bovis have been restudied and identified as S. mutans. S. mutans has also been confused with enterococci. It may be important clinically that streptococci isolated as causes of endocarditis be classified correctly, because the nonenterococcal streptococci are much more susceptible to appropriate antibiotics than are enterococci (3, 11; C. Thornsberry et al., submitted for publication). Although S. mutans organisms may share some characteristics with group D streptococci, such as a positive bile-esculin test, they will not grow in broth containing 6.5% NaCl; they can therefore be classified as nonenterococcus streptococci on this basis. The susceptibility data for these strains of S. mutans are similar to those for other viridans streptococci and are different from those for-enterococci (C. Thornsberry et al., submitted for publication).
Performing susceptibility tests on S. mutans presents some technical problems. These organisms grow slowly and will not grow on solid media unless the incubation atmosphere contains 5 to 10% CO2. They grow very poorly or not at all in Mueller-Hinton broth (commonly used for susceptibility tests), but they grow better in TSB. Therefore, the latter broth was used in these tests. Even when TSB and a CO2 atmosphere were used, growth was still relatively slow. With a few strains, growth was considered to be inadequate for susceptibility tests even after 48 h. These strains were not tested further. Agar diffusion disk susceptibility tests should not be used for S. mutans because of its slow growth. Although growth up to the disk (i.e., complete resistance) may be useful clinical information, zones of inhibition cannot be correlated with clinical susceptibility.
There was considerable variation in the MBCs obtained for all of the antibiotics tested, but for penicillin, the antibiotic that is most often used to treat streptococcal endocarditis (often in combination with an aminoglycoside), most of the MBCs were low. Seventy percent of the strains had MBCs for penicillin of 0.08 ,ug/ml or less; 85% were less than 1.0 gg/ml.
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on October 15, 2017 by guest http://aac.asm.org/ Downloaded from used in conjunction with penicillin to achieve a synergistic action on the bacteria. However, based on these in vitro data, it is possible that gentamicin may offer an advantage over streptomycin, because the MBCs for gentamicin are, for many strains, lower than for streptomycin. This view is supported by the results of other investigators (10) .
Preliminary studies in our laboratory have shown that MBC determinations are very method dependent and are also greatly influenced by the definition of the end point. MBC tests were performed in the present study by transferring 0.025 ml of a total volume of 0.1 ml to blood agar plates which were then incubated for 48 h at 35 C in a candle jar. The end point was defined as total inhibition of growth. If we had used a different end point as, for example, either 10 (8) . Therefore, an antimicrobial susceptibility test should be performed on all isolates. These tests should be done either by broth or agar dilution. If an MBC is desired, broth dilution should be used. Agar diffusion tests should not be used to test streptococci from endocarditis. If the nonenterococcal isolate is relatively resistant to penicillin, the therapeutic regimen probably should be the same as that for enterococci (5) .
